Neuroimaging In Cockayne Syndrome

SUMMARY: CS is an autosomal recessive multisystem disorder, which is mainly characterized by neurologic and sensory impairment, cachectic dwarfism, and photosensitivity. We describe the neuroimaging features (MR imaging, 1H-MR spectroscopy, and CT) in the various clinical subtypes of CS from a cohort of genetically and biochemically proved cases. Hypomyelination, calcifications, and brain atrophy were the main imaging features. Calcifications were typically found in the putamen and less often in the cortex and dentate nuclei. Severe progressive atrophy was seen in the supratentorial white matter, the cerebellum, the corpus callosum, and the brain stem. Patients with early-onset disease displayed more severe hypomyelination and prominent calcifications in the sulcal depth of the cerebral cortex, but atrophy was less severe in late-onset patients. On proton MR spectroscopy, lactate was detected and Cho and NAA values were decreased. These combined neuroradiologic findings can help in the differential diagnosis of CS, distinguishing it from other leukoencephalopathies and/or cerebral calcifications in childhood.'

[1]  Y. Crow,et al.  Aicardi-Goutières Syndrome: Neuroradiologic Findings and Follow-Up , 2009, American Journal of Neuroradiology.

[2]  D. Dickson,et al.  Neuropathology of Cockayne syndrome: Evidence for impaired development, premature aging, and neurodegeneration , 2009, Mechanisms of Ageing and Development.

[3]  E. Lüleci,et al.  Tigroid pattern on magnetic resonance imaging in Lowe syndrome , 2009, Journal of Clinical Neuroscience.

[4]  B. Dan,et al.  Pelizaeus–Merzbacher–Like disease presentation of MCT8 mutated male subjects , 2009, Annals of neurology.

[5]  A. Bizzi,et al.  Classification of Childhood White Matter Disorders Using Proton MR Spectroscopic Imaging , 2008, American Journal of Neuroradiology.

[6]  T. Nouspikel Nucleotide excision repair and neurological diseases. , 2008, DNA repair.

[7]  P. J. Brooks,et al.  Do all of the neurologic diseases in patients with DNA repair gene mutations result from the accumulation of DNA damage? , 2008, DNA repair.

[8]  A. Lehmann,et al.  Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. , 2008, DNA repair.

[9]  J. Marescaux,et al.  Neurological defects in trichothiodystrophy reveal a coactivator function of TFIIH , 2007, Nature Neuroscience.

[10]  S. Katyal,et al.  DNA Repair Deficiency and Neurodegeneration , 2007, Cell cycle.

[11]  E. Huang,et al.  Increased apoptosis, p53 up-regulation, and cerebellar neuronal degeneration in repair-deficient Cockayne syndrome mice , 2007, Proceedings of the National Academy of Sciences.

[12]  S. Merchant,et al.  Cockayne Syndrome in Adults: Review With Clinical and Pathologic Study of a New Case , 2006, Journal of child neurology.

[13]  A. Hart,et al.  Childhood white matter disorders: quantitative MR imaging and spectroscopy. , 2006, Radiology.

[14]  S. Uǧur,et al.  Severe Form of Cockayne Syndrome With Varying Clinical Presentation and No Photosensitivity in a Family , 2006, Journal of child neurology.

[15]  T. Hosoya,et al.  MR findings of cerebral white matter in Cockayne syndrome. , 2006, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[16]  R. A. Zimmerman,et al.  Ataxia-telangiectasia: the pattern of cerebellar atrophy on MRI , 2003, Neuroradiology.

[17]  J. Hoeijmakers,et al.  Early postnatal ataxia and abnormal cerebellar development in mice lacking Xeroderma pigmentosum Group A and Cockayne Syndrome Group B DNA repair genes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  I. Rapin,et al.  Cockayne syndrome and xeroderma pigmentosum , 2000, Neurology.

[19]  M. Oda,et al.  Neurodegeneration in hereditary nucleotide repair disorders , 1999, Brain and Development.

[20]  E. Zackai,et al.  Neuropathological Findings in Eight Children with Cerebro‐oculo‐facio‐skeletal (COFS) Syndrome , 1997, Journal of neuropathology and experimental neurology.

[21]  S. Provencher Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[22]  B. Harding,et al.  Early onset Cockayne's syndrome: case reports with neuropathological and fibroblast studies. , 1989, Journal of medical genetics.

[23]  O. Dabbagh,et al.  Cockayne syndrome: MRI correlates of hypomyelination. , 1988, Pediatric neurology.

[24]  C. Kim Congenital and perinatal cytomegalovirus infection , 2010 .

[25]  R. Tarone,et al.  Cockayne Syndrome: Clinicopathologic and Tissue Culture Studies of Affected Siblings , 1985, Journal of neuropathology and experimental neurology.

[26]  O. Khan Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination. , 2006, Neurology.

[27]  B. Kendall,et al.  Cranial CT and MRI in diseases with DNA repair defects , 2004, Neuroradiology.

[28]  A. Valavanis,et al.  MRI in Cockayne syndrome type I , 2004, Neuroradiology.

[29]  M. Nance,et al.  Cockayne syndrome: review of 140 cases. , 1992, American journal of medical genetics.

[30]  J. Valk,et al.  The reflection of histology in MR imaging of Pelizaeus-Merzbacher disease. , 1989, AJNR. American journal of neuroradiology.